Nexgenia

About:

Nexgenia develops and manufactures proprietary stimuli-responsive polymers and polymer-containing magnetic nanoparticles.

Website: https://www.nexgeniacorp.com

Top Investors: Alliance of Angels, Washington Research Foundation, W Fund

Description:

Nexgenia develops and manufactures proprietary stimuli-responsive polymers and polymer-containing magnetic nanoparticles. These polymers change state from soluble single macromolecules to large insoluble aggregates in response to very modest changes (like temperature, pH, and salt) in their environment. When these polymers are attached to other chemicals/biologicals, they confer the same environmentally-responsive characteristics. Thus the resulting combinations can be small when it is advantageous to be small and large when that facilitates separation and analysis. This property enables the development of faster, more complete molecular/cellular separations and faster, more sensitive immunoassays. Nexgenia was founded in 2011 and is headquartered in Seattle, Washington.

Total Funding Amount:

$3.48M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)nexgeniacorp.com

Founders:

James Lai, Patrick Stayton

Number of Employees:

1-10

Last Funding Date:

2016-08-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai